Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study

Post time Half hour(s) ago

Nadia E Aikawa, Ana C Medeiros-Ribeiro, Sandra G Pasoto, Leonard V K Kupa, Luciana P C Seguro, Ana P Luppino-Assad, Eduardo F Borba, Carla G S Saad, Emily F N Yuki, Danieli C O Andrade, Andrea Y Shimabuco, Karina R Bonfiglioli, Diogo S Domiciano, Julio C B Moares, Samuel K Shinjo, Percival D Sampaio-Barros, Henrique A M Giardini, João C S de Oliveira, Isabele P B Antonelli, Renata L P Mello, Thais B Gorayeb, Lucas G N Farias, Andrea A Negrini, Fernanda G G Chaer, Ana C S L Praxedes, Marta H Lopes, Clovis A Silva, Eloisa Bonfa,
Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study,
The Lancet Rheumatology,
Volume 8, Issue 5,
2026,
Pages e363-e376,
ISSN 2665-9913,

LINK: https://www.sciencedirect.com/sc ... i/S2665991325003133

DOI: https://doi.org/10.1016/S2665-9913(25)00313-3

Post time Half hour(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study